Company intelligence / Profile preview

bitBiome

Ownership
Private
Development stage
Commercial
01

Overview

bitBiome has developed the world’s first single-cell genomics technology tailored to microorganisms. Their proprietary platforms enable the accurate decoding of complete genomes from individual microbial cells—unlocking vast numbers of previously inaccessible genes (“dark matter” genes). The company leverages this data to discover novel enzymes and genetic functions useful in biomanufacturing, environmental sustainability, and potentially healthcare. They have built one of the world’s largest microbial genome databases (>800 million microbe genes), supporting both internal projects and external collaborations with industry partners. Clinical results are not applicable as their focus is on enabling technologies/platforms rather than direct therapeutic products.

Therapeutic areas
OtherGastroenterology
Modalities
Enzyme discovery and engineeringmicrobial genome analysis
Industry
Non-Drug Biotech
02

Partnerships

Collaborations with academic institutions such as Waseda UniversityPartnerships with industry clients across pharmaceutical, chemical, food sectors

Beyond the preview

Go deeper on bitBiome.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bitBiome.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call